Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX. - Wikidata - wikimedia - TriplyDB

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

http://www.wikidata.org/entity/Q30383193

about

Applications of CRISPR genome editing technology in drug target identification and validation.Genome editing using FACS enrichment of nuclease-expressing cells and indel detection by amplicon analysis.Expression of Flp Protein in a Baculovirus/Insect Cell System for Biotechnological Applications.In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1.CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS).Peptide/Cas9 nanostructures for ribonucleoprotein cell membrane transport and gene edition.In vivo methods for acute modulation of gene expression in the central nervous system Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA induces homology-directed DNA repair Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo

P2860

Q38708498-77366AA1-871C-4B39-AC95-15C2EB2D8D32 Q38716194-43998F98-0219-4164-8B84-A8DB871C0B5B Q40141675-0A0C2D07-DDEC-4E40-8543-072D55659E1D Q40263108-DFFA113D-B2F5-4A8D-970A-A830A47EF3AE Q41044192-DC03189C-DE7E-4069-ACF7-7F666C7A77DD Q52430933-D5FB6BF9-480B-4CA4-ABE1-D586FF30292A Q52431312-04B4522E-2084-44FC-8F58-4660C328C0AC Q57020987-9EF4A570-95E7-40AC-B60D-374EFA7BF0C0 Q58054257-0FD21B34-8B53-4B21-8A72-4D2FDC0B47B8 Q58771152-C4E0F026-F3FE-4803-8B1A-F3C1775A75C8

P2860

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

http://www.wikidata.org/entity/Q30383193

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

@ast

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

@en

type

label

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

@ast

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

@en

prefLabel

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

@ast

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

@en

P1433

Q30383193-C98CB3FE-FDD0-4826-A2BE-E11054641BE6

P1476

Q30383193-6ED0940A-CE54-4E8F-B223-8AD98A10A1D3

P2093

Q30383193-15695FA1-FC24-4A1C-9D2B-B1114E310105

Q30383193-1B646159-3D83-44FD-96BB-A5226F87F6B1

Q30383193-3D11EB75-C236-41A8-BFB3-1F8DE7421D21

Q30383193-3D1E1876-E944-4759-BFC7-308325327873

Q30383193-7C9876D5-4748-432C-BBAE-D2F3BD3C7EFB

Q30383193-E0B9B058-4061-4876-8025-D4118852B758

Q30383193-E4A7DBFF-9B08-4591-A85A-BC8E6A4E1A90

P2860

Q30383193-22554E43-5513-43B5-A01E-3E1FF99EA054

Q30383193-32EC011B-347A-4F87-AB00-C834323BFEA4

Q30383193-55DB2FEE-57CF-4373-8878-11D549926CF8

Q30383193-8E8741FC-6826-49E9-8D90-E1127C393136

Q30383193-95C71E48-8A34-4C6D-B6F2-EB8F31CDD39F

Q30383193-AA04E6D9-8B9F-4A99-9845-F1D92CCE8360

Q30383193-D748D938-6427-4FB6-B67D-1EAC0F8A0EE0

Q30383193-DA189B7A-7377-4A7D-93AA-B5E24E16D98B

Q30383193-E3937328-3723-4EA0-A25A-1F7F7A55878B

Q30383193-EAC11EE3-8224-4487-8554-B06540E9B310

P2888

Q30383193-136DF149-6FCD-4274-9391-F3368B79EBAE

P304

Q30383193-99F11F62-C083-4755-8962-0FE09B320D22

P31

Q30383193-E25FE44B-5105-4F16-A814-4C608DE5FD7C

P356

Q30383193-BBFD8EF8-61DA-4879-8837-2BC974573D57

P433

Q30383193-1707D072-D48B-40BB-A55D-658999FE047B

P478

Q30383193-21646317-1E3C-4DD0-826C-EB85FE512873

P50

Q30383193-A6C4CAF0-89AF-4D85-8187-0AC8C2775C04

P577

Q30383193-957DF27D-3BE3-462C-B865-472A2768BAFB

P5875

Q30383193-CFC433C5-CD91-4502-AF65-BAE170333D6E

P698

Q30383193-B9EC3F9D-B5CE-4BA4-BFF6-EA5A927AF9FC

P932

Q30383193-54031F86-D237-4205-BC90-3B418932FE98

P356

S10529-016-2064-9

P1433

Biotechnology Letters

P1476

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX.

@en

P2093

Huimin Xie

http://www.w3.org/2001/XMLSchema#string

Jason Potter

http://www.w3.org/2001/XMLSchema#string

Jonathan D Chesnut

http://www.w3.org/2001/XMLSchema#string

Namritha Ravinder

http://www.w3.org/2001/XMLSchema#string

Shantanu Kumar

http://www.w3.org/2001/XMLSchema#string

Xavier de Mollerat du Jeu

http://www.w3.org/2001/XMLSchema#string

Xin Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins.

Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.

Protein delivery into live cells by incubation with an endosomolytic agent

Cell-penetrating peptides: design, synthesis, and applications.

Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery.

Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects.

Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine

Cell-penetrating peptide (CPP)-conjugated proteins is an efficient tool for manipulation of human mesenchymal stromal cells.

Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells.

P2888

s10529-016-2064-9

P304

919-929

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10529-016-2064-9

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295089583

http://www.w3.org/2001/XMLSchema#string

P698

26892225

http://www.w3.org/2001/XMLSchema#string

P932

4853464

http://www.w3.org/2001/XMLSchema#string